Dr. Martens plc

LSE:DOCS Rapporto sulle azioni

Cap. di mercato: UK£526.3m

Dr. Martens Crescita futura

Future criteri di controllo 1/6

Dr. Martens prevede che gli utili e i ricavi cresceranno rispettivamente di 5.7% e 2.8% all'anno. Si prevede che l'EPS crescerà di 5.2% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 15.8% in 3 anni.

Informazioni chiave

5.7%

Tasso di crescita degli utili

5.2%

Tasso di crescita dell'EPS

Luxury crescita degli utili9.7%
Tasso di crescita dei ricavi2.8%
Rendimento futuro del capitale proprio15.8%
Copertura analitica

Good

Ultimo aggiornamento25 Oct 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet

Sep 21
Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet

Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?

Aug 20
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?

Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger

Jul 20
Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger

There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings

Jun 19
There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings

Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%

May 21
Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Mar 27
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Mar 06
Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Feb 08
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Jan 21
Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Jan 03
Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dec 13
Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Oct 12
Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Sep 13
Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

Jul 12
Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Jun 02
A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Feb 25
Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

Dec 17
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Oct 02
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Jul 04
Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Jun 16
Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Mar 02
Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Dec 01
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Previsioni di crescita degli utili e dei ricavi

LSE:DOCS - Stime future degli analisti e dati finanziari passati (GBP Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202794074921966
3/31/202688056841627
3/31/202582428771487
3/31/202487769140168N/A
12/31/20239278682120N/A
9/30/20239781032877N/A
6/30/20239891162777N/A
3/31/20231,0001292173N/A
12/31/202297915362105N/A
9/30/2022957177104138N/A
6/30/2022933179132161N/A
3/31/2022908181159184N/A
12/31/2021867118129151N/A
9/30/20218255498117N/A
6/30/202179944120138N/A
3/31/202177335142159N/A
12/31/202074761156175N/A
9/30/202072287169190N/A
6/30/202069781134156N/A
3/31/202067275100121N/A
3/31/2019454173956N/A
3/31/2018349-63046N/A
3/31/2017291-11N/A34N/A
3/31/2016232-12N/A26N/A
3/31/20152350N/A20N/A
3/31/2014164-32N/A5N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di DOCS ( 5.7% all'anno) è superiore al tasso di risparmio ( 1.9% ).

Guadagni vs Mercato: Si prevede che gli utili di DOCS ( 5.7% all'anno) cresceranno più lentamente rispetto al mercato UK ( 14.6% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di DOCS cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di DOCS ( 2.8% all'anno) crescerà più lentamente rispetto al mercato UK ( 3.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di DOCS ( 2.8% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di DOCS sarà basso tra 3 anni ( 15.8 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y